Rekvina Labs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE092O01028
  • NSEID:
  • BSEID: 526075
INR
7.43
0.35 (4.94%)
BSENSE

Jan 14

BSE+NSE Vol: 250

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 576337,
    "name": "Rekvina Labs",
    "stock_name": "Rekvina Labs",
    "full_name": "Rekvina Labs Ltd",
    "name_url": "stocks-analysis/rekvina-labs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "7.43",
    "chg": 0.35,
    "chgp": "4.94%",
    "dir": 1,
    "prev_price": "7.08",
    "mcapval": "4.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 526075,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE092O01028",
    "curr_date": "Jan 14",
    "curr_time": "",
    "bse_nse_vol": "250 ",
    "exc_status": "Active",
    "traded_date": "Jan 14, 2026",
    "traded_date_str": "2026 01 14",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/rekvina-labs-576337-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Rekvina Labs Hits New 52-Week High of Rs.7.43 on 14 Jan 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rekvina-labs-hits-new-52-week-high-of-rs743-on-14-jan-2026-3791571",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/RekvinaLabs_priceRelatedfactors_3791571.png",
        "date": "2026-01-14 09:51:02",
        "description": "Rekvina Labs Ltd reached a fresh 52-week high today, closing at Rs.7.43, reflecting a notable surge in momentum despite broader market softness. This milestone underscores the stock’s recent strength as it outperformed its sector and maintained a position above all key moving averages."
      }
    ],
    "total": 1,
    "sid": "576337",
    "stock_news_url": "https://www.marketsmojo.com/news/rekvina-labs-576337"
  },
  "announcements": [
    {
      "details": "Submission of Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018",
      "datetime": "29-Jul-2019 18:12",
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
      "source": "BSE"
    },
    {
      "details": "Rekvina Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly <a href=\"http://www.bseindia.com/corporates/shpSecurities.aspx?scripcd=526075&qtrid=102.00\">Click here</a>",
      "datetime": "20-Jul-2019 10:42",
      "caption": "Shareholding for the Period Ended June 30, 2019",
      "source": "BSE"
    },
    {
      "details": "<table border=1><tr bgcolor=#d6d6d6><th class=TTRow_left> No.of Investor complaints pending at the beginning of the quarter </th><th class=TTRow> No.of Investor complaints received during the quarter</th><th class=TTRow> No.of Investor complaints disposed of during the quarter </th><th class=TTRow> No.of Investor complaints unresolved at the end of the quarter </th></tr><tr><td class=TTRow>0</td><td class=TTRow>0</td><td class=TTRow>0</td><td class=TTRow>0</td></tr></table><table border=1><tr><td > <span style=font-weight:bold>Name of the Signatory </span> </td><td> :- </td><td>Mukesh Shah</td></tr><tr><td ><span style=font-weight:bold>Designation </span></td><td> :- </td><td>Director</td></tr></table>",
      "datetime": "18-Jul-2019 17:45",
      "caption": "Statement Of Investor Complaints For The Quarter Ended June 2019",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Rekvina Labs Ltd has announced <strong>5:10</strong> stock split, ex-date: 30 Apr 14",
          "dt": "2014-04-30",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

29-Jul-2019 18:12 | Source : BSE

Submission of Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018

Shareholding for the Period Ended June 30, 2019

20-Jul-2019 10:42 | Source : BSE

Rekvina Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click here

Statement Of Investor Complaints For The Quarter Ended June 2019

18-Jul-2019 17:45 | Source : BSE

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
0000
Name of the Signatory :- Mukesh Shah
Designation :- Director

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

Rekvina Labs Ltd has announced 5:10 stock split, ex-date: 30 Apr 14

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available